Skip to main content

Table 2 The demographic characteristics of the recruited participants from the seven HDSS sites

From: Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health facilities in four African countries

Variable

Main group n (%)

Nested cohort n (%)

Total n (%)

Age

 6–11 months

327 (3.4)

6 (0.6)

333 (3.1)

 12–59 months

4327 (45.1)

325 (32.4)

4652 (43.9)

 Above 59 months

4935 (51.5)

671 (67.0)

5606 (52.9)

Enrolment

 Eligible

9589 (98.0)

1002 (76.2)

10,591 (95.4)

 Excluded

68 (0.7)

12 (0.9)

80 (0.7)

 Withdrawn

125 (1.3)

301 (22.9)

426 (3.8)

Sex

 Male

4521 (47.2)

489 (48.2)

5004 (47.3)

 Female

5068 (52.8)

518 (51.7)

5586 (52.7)

Country/site

 Burkina faso

  

3017 (28.5)

 Nouna

1658 (17.3)

102 (10.2)

1760 (16.6)

 Nanoro

1060 (11.1)

197 (19.7)

1257 (11.9)

 Ghana

  

4563 (43.1)

 Dodowa

729 (7.6)

155 (15.6)

884 (8.4)

 Kintampo

1763 (18.4)

15 (1.5)

1778 (16.8)

 Navrongo

1627 (17.0)

274 (27.4)

1901 (17.9)

 Mozambique

  

1965 (18.6)

 Manhiça

1876 (19.6)

89 (8.9)

1965 (18.6)

 Tanzania

  

1046 (9.9)

 Rufiji

876 (9.1)

170 (17.0)

1046 (9.9)